Kwangdong’s U to emerge as lead market

Kwangdong Pharm’s Uwhangchungsimwon (UC) is likely to regain its momentum as the market’s leading player Chosun Pharm is unable to release its products due to in-house problems, according to pharmaceutical business sources.

UC has been known to have a preventive effect on ischemia-induced brain damage and recovery effect on ischemia in older people.

Kwangdong has endeavored to expand UC t...